Clinical Trials at Henry Ford Health
As of September 2026, 49 paid clinical trials are recruiting at Henry Ford Health, located at 2799 W GRAND BLVD, DETROIT, MI 48202-2608, phone (313) 916-2600 in Detroit, Michigan. Active studies at this site cover conditions such as Endometrial Cancer, Advanced Solid Tumor and Breast Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
View the full facility profile →
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Detroit
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Examining the Impact of the Parenting Young Children Check-up
51 clinical trials at Henry Ford Health
·Clear filters·Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
ELEVATE High-Risk PCI Pivotal Study
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Global Paradise System US Post Approval Study
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors
An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
Exactech Shoulder Post Market Clinical Follow-up Study
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
Serranator POINT FORCE Registry
Nafamostat Efficacy in Phase 3 Registrational CRRT Study
HPC Offered for PRESERVE Expansion
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
PREVENT ALL ALS Study
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
ASSESS ALL ALS Study
UPBEAT: Using Polygenic Scores to Guide BB Therapy in HF With Mildly Reduced EF
Efficacy of Ketorolac for Postoperative Pain Management in Hip Arthroscopy
A Comparison of Radical Prostatectomy and Precision Prostatectomy in Low- and Intermediate-risk Prostate Cancers.
Project 4: ACHIEVE PATHFINDER
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery
Common conditions studied in Detroit
- Endometrial Cancer (14 active studies)
- Advanced Solid Tumor (13 active studies)
- Breast Cancer (13 active studies)
- Heart Failure (13 active studies)
- Ovarian Cancer (12 active studies)
- Multiple Myeloma (11 active studies)
Leading research sponsors in Detroit
- Henry Ford Health System
- National Cancer Institute (NCI)
- AstraZeneca
- Wayne State University
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in Detroit?
There are approximately 719 recruiting clinical trials in Detroit, Michigan listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Detroit pay participants?
Most recruiting trials in Detroit compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Detroit?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Detroit?
The most common conditions under active study in Detroit include Endometrial Cancer (14), Advanced Solid Tumor (13), Breast Cancer (13), Heart Failure (13), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Detroit?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Detroit on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Detroit?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Detroit?
Recruiting research sites in Detroit include Henry Ford Hospital, Karmanos Cancer Institute, Henry Ford Health System, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Detroit right now?
The largest active categories in Detroit are Cancer & tumors (303), Cardiovascular (51), Neurology & pain (27). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Henry Ford Health?
Henry Ford Health is located at 2799 W GRAND BLVD, DETROIT, MI 48202-2608. Use the Google Maps link in the intro above to get directions.
How do I contact Henry Ford Health?
You can reach Henry Ford Health by phone at (313) 916-2600. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.